U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released a following statement after the U.S. House on Friday and U.S. Senate today passed the Further Consolidated Appropriations Act of 2024.
The Chamber shaped pro-business outcomes for the most urgent issues while also advancing debates around topics that will determine U.S. competitiveness for years to come.
Biden Wants to Revoke Federally Funded Patents if Products Are Too Expensive thenewamerican.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewamerican.com Daily Mail and Mail on Sunday newspapers.
Senator Thom Tillis sent a letter today to President Joe Biden asking him to answer three broad questions related to his proposal earlier this month that would allow government agencies considerable discretion in deciding whether and when to “march in” on patents.
Washington, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley issued the following statement in reaction to the Biden Administration's unprecedented decision to seize certain drug patents.“The Biden administration’s conclusion that they have the authority to seize patents for certain medicines not only contradicts the law, it contradicts the conclusion of prior Republican and Democratic administrations. This move will result in fewer medical breakthroughs, ultimately hurting patients.“Let’s be clear, seizing patents is a confiscation of property. If patents for medicine are seized today, what property will the government seize tomorrow? The Chamber will use every tool at our disposal to stop the Administration from destroying America's ability to discover the next breakthrough treatment or cure.”##